Clinical Trial Update: Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates Seclidemstat in combination with azacitidine is being studied for myelodysplastic syndrome or chronic myelomonocytic leukemia in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Seclidemstat (seclidemstat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING